SCHEMBL6209320

SCHEMBL6209320

CSc1sc(C(=N)N)cc1S(=O)(=O)c1ccc(CN2CCOCC2)c(-c2ccccc2C)c1

nearest known ligand 0.59

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
C1S P09871 20/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5841499 0.84 C1S (0.73) C1S
SCHEMBL5840976 0.80 C1S (0.73) C1S
SCHEMBL13946250 0.75 C1S (1.00) C1S
SCHEMBL8363359 0.75 C1S (0.74) C1S
SCHEMBL8363773 0.74 C1S (0.69) C1S
Trifluoroacetic Acid SCHEMBL5840978 0.74 C1S (0.64) C1S
SCHEMBL5841183 0.74 C1S (0.67) C1S
SCHEMBL5840539 0.73 C1S (0.60) C1S
SCHEMBL8363808 0.72 C1S (0.56) C1S
Trifluoroacetic Acid SCHEMBL6209554 0.72 C1S (0.50) C1S

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1549632-A4 NOVEL THIOPHENE AMIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATING COMPLEMENT-MEDIATED DISEASES AND CONDITIONS DIMENSIONAL PHARM INC (US) 2005-11-09 EP disclosed
EP-1549632-A1 NOVEL THIOPHENE AMIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATING COMPLEMENT-MEDIATED DISEASES AND CONDITIONS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2005-07-06 EP disclosed
WO-2003099805-A1 NOVEL THIOPHENE AMIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATING COMPLEMENT-MEDIATED DISEASES AND CONDITIONS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2003-12-04 WO disclosed